Europe
EU Watch
EU regulators approve tolebrutinib, now Cenrifki, for nonrelapsing SPMS
Source: news.google.com
Published: Jun 24, 2026 23:18
EU regulators approve tolebrutinib, now Cenrifki, for nonrelapsing SPMS Multiple Sclerosis News Today
Detailed source content is still being fetched from the original article. Use the source link above for the live story.